Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Insulin-Like Growth Facto… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Insulin-Like Growth Factor-1 and Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Has the Time Come?

Artikel i vetenskaplig tidskrift
Författare A. Stahl
Ann Hellström
L. E. H. Smith
Publicerad i Neonatology
Volym 106
Nummer/häfte 3
Sidor 254-260
ISSN 1661-7800
Publiceringsår 2014
Publicerad vid Institutionen för neurovetenskap och fysiologi
Sidor 254-260
Språk en
Länkar dx.doi.org/10.1159/000365132
Ämnesord Insulin-like growth factor 1, Preterm birth, Retinopathy of prematurity, Vascular endothelial growth, POSTNATAL WEIGHT-GAIN, INTRAVITREAL BEVACIZUMAB, IGF-I, LASER, PHOTOCOAGULATION, MACULAR DEGENERATION, PRETERM INFANTS, PLASMA-LEVELS, INJECTION, ANGIOGENESIS, PREDICTION, Pediatrics
Ämneskategorier Klinisk medicin

Sammanfattning

Treatment of retinopathy of prematurity (ROP) is currently evolving. Novel therapeutic options are emerging that have the potential to complement existing therapies and improve treatment outcomes. However, any new therapeutic option must be thoroughly evaluated before existing (and successful) treatment paradigms can be amended. This is particularly so when switching from locally effective therapies like photoablative laser therapy to systemic pharmacological treatments, which may have hitherto unknown widespread side effects. This review compiles the current knowledge of where and when the two most advanced pharmacological treatment options for ROP, insulin-like growth factor-1 supplementation and anti-vascular endothelial growth factor treatment, may have their place in future therapy regimens for ROP. The requirement for clinical studies is emphasized: these are needed to address safety considerations before any of these interventions can achieve the status of standard clinical care in the very vulnerable population of ROP infants.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?